Inherent abnormalities in oxidative metabolism in Alzheimer's disease: Interaction with vascular abnormalities

Annals of the New York Academy of Sciences

Volumn 826, Issue , 1997, Pages 382-385

  Blass, John P ^a,c   Sheu, Kwan R ^a   Piacentini, Silvia ^b   Sorbi, Sandro ^b  

^a Cornell University ^*  (United States)

^b UNIVERSITY OF FLORENCE   (Italy)

^c BURKE MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

AEROBIC METABOLISM; ALZHEIMER DISEASE; BRAIN INJURY; BRAIN METABOLISM; BRAIN OXYGEN CONSUMPTION; CONFERENCE PAPER; ENERGY METABOLISM; FIBROBLAST; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOLECULAR GENETICS; VASCULAR DISEASE;

EID: 0030709194     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48488.x     Document Type: Conference Paper

References (27)

1. BLASS, J. P. 1993. Pathophysiology of the Alzheimer syndrome. Neurology 43(Suppl 4): S25-S38.
2. BLASS, J. P. 1996. Energy/glucose metabolism in neurodegenerative diseases. In Molecular Mechanisms of Dementia. W. Wasco & R. E. Tanzi, Eds.: 91-101. Humana Press. Totawa, NJ.
3. REIMAN, E. M. et al. 1996. Preclinical evidence of Alzheimer's disease in persons homozygous for the e4 allele for apolipoprotein E. N. Engl. J. Med. 334: 752-758.
4. SMALL, G. W., J. C. MAZZIOTTA & M. T. COLLINS. 1995. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. J. Am. Med. Assoc. 273: 942-947.
5. KENNEDY, A. M., R. S. J. FRACKOWIAK & S. K. NEWMAN. 1995. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci. Lett. 186: 1270.
6. CRAFT, S., G. ZALLEN & L. BAKER. 1992. Glucose and memory in mild senile dementia of the Alzheimer type. J. Clin. Exptl. Neuropsychol. 14: 253-266.
7. CRAFT, S. et al. 1995. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol. Aging 17: 123-130.
8. MANNING, C., M. RAGOZZINO & P. E. GOLD. 1993. Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer type. Neurobiol. Aging 14: 523-529.
9. SHEU, K.-F. R. et al. 1994. Abnormality in the α-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease. Ann. Neurol. 35: 312-318.
10. SORBI, S., E. D. BIRD & J. P. BLASS. 1983. Decreased pyruvate dehydrogenase activity in Huntington and Alzheimer brain. Ann. Neurol. 13: 72-78.
11. PARKER, W. D., C. M. FILLEY & J. K. PARKS. 1990. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 42: 1302-1304.
12. VAN ZUYLEN, A. J., G. J. G. C. M. BOSMAN & W. RUITENBECK. 1992. No evidence for reduced thrombocyte cytochrome oxidase activity in Alzheimer's disease. Neurology 42:
13. CHANDRAKASARAN, K. et al. 1994. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer's disease. Brain Res. (Mol. Brain Res.) 24: 336-340.
14. ALI, G. et al. 1994. Isolation, cloning, and localization of the gene for the E2k component of the human α-ketoglutarate dehydrogenase complex. Somatic Cell Mol. Genet. 20: 99-104.
15. NAKANO, K., C. TAKASE & T. SAKAMOTO. 1994. Isolation, characterization, and structural organization of the gene and pseudogene for the dihydrolipoyl succinyltransferase component of the 2-oxoglutarate dehydrogenase complex. Eur. J. Biochem. 224: 179-186.
16. CAI, X. et al. 1994. A pseudogene of dihydrolipoyl succinyltransferase (E2k) found by PCR amplification and direct sequencing in rodent-human cell hybrid DNAs. Somatic Cell Mol. Genet. 20: 339-343.
17. SZABO, P. et al. 1994. Localization of the gene (OGDH) coding for the Elk component of the α-ketoglutarate dehydrogenase complex to chromosome 7pl3-pll.2. Genomics 20: 324-327.
18. SCHERER, S. W. et al. Localization of the human dihydrolipoamide dehydrogense gene (DLD) to 7q31-7q32. Cytogenet. Cell Genet. 56: 176-180.
19. GIBSON, G. E., W. A. PULSINELLI & J. P. BLASS. 1981. Brain dysfunction in mild to moderate hypoxia. Am. J. Med. 70: 1247-1255.
20. GIBSON, G. E., M. SHIMADA & J. P. BLASS. 1978. Alterations in acetylcholine synthesis and in cyclic nucleotides in mild cerebral hypoxia. J. Neurochem. 31: 757-760.
21. BEAL, F. M. 1992. Does impairment of energy metabolism result in excitotoxic death in neurodegenerative diseases? Ann. Neurol. 31: 119-122.
22. HUANG, H.-M. & G. E. GIBSON. 1993. Altered β-adrenergic receptor-stimulated cAMP formation in cultured skin fibroblasts from Alzheimer donors. J. Biol. Chem. 268: 14616-14622.
23. HUANG, H. M., L. TORAL-BARZA & G. E. GIBSON. 1991. Cytosolic free calcium and ATP in synaptosomes after ischemia. Life Sci. 48: 1439-1445.
24. BLASS, J. P. et al. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. Arch Neurol. 28: 111-117.
25. KALARIA, R. N. et al. The amyloid precursor protein in ischemic brain injury and chronic hypoperfusion. Ann. N. Y. Acad. Sci. 695: 190-199.
26. BLASS, J. P., K.-F. R. SHEU & J. M. CEDERBAUM. 1988. Energy metabolism in disorders of the nervous system. Rev. Neurol. (Paris) 147: 513-522.
27. BLASS, J. P. 1996. Cerebral metabolic impairments. In Alzheimer's Disease: Cause(s), Diagnosis, Treatment and Care. Z. S. Khachaturian & T. S. Radebaugh, Eds.: 187-205. CRC Press. Boca Raton, FL.